Marksans Pharma

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE750C01026
  • NSEID: MARKSANS
  • BSEID: 524404
INR
337.60
-9.85 (-2.83%)
BSENSE

Sep 24, 03:30 PM

BSE+NSE Vol: 30.05 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryMarksans Pharma VS Pharmaceuticals & Biotechnology
 
1D
-2.83%
-1.67%
1W
5.78%
-0.99%
1M
4.2%
-4.9%
YTD
87.4%
-13.66%
1Y
98.35%
-9.96%
3Y
222.91%
11.47%
5Y
389.28%
22.54%
10Y
605.54%
156.66%
  • Stock Absolute Returns
  • India SENSEXAbsolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0.26%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
28.19%
0.34%
28.53%
6 Months
104.73%
0.57%
105.3%
1 Year
98.35%
0.54%
98.89%
2 Years
9.59%
0.59%
10.18%
3 Years
222.91%
2.15%
225.06%
4 Years
584.79%
5.88%
590.67%
5 Years
389.28%
4.53%
393.81%

Latest dividend: 0.9029572836801752 per share ex-dividend date: Aug-20-2026

stock-summaryReturn Quartiles
What is a Quartile?

Quartile analysis gives a quick view of the performance of the stock with its peers and with the overall market. Companies are bucketed in 4 Quartiles as per their total returns generated; with each quartile consisting of 25% of the companies in the category.


Example: If there are 20 companies in an industry, the top 5 return giving companies would be bucketed in 1st quartile, next 5 companies in 2nd quartile and so on

Return Quartiles - by Closest Peers stock-summary
Inconsistent Performance

Marksans Pharma Ltd has not been a consistent performer in the YTD and longer periods

2
Quartile
quartile-2
QTD
27.72%
1
Quartile
quartile-1
Mar-Jun
73.11%
3
Quartile
quartile-3
Dec-Mar
-12.77%
1
Quartile
quartile-1
YTD
104.14%
4
Quartile
quartile-4
2025
-39.28%
2
Quartile
quartile-2
2024
84.46%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Industry stock-summary
Inconsistent Performance

Marksans Pharma Ltd has not been a consistent performer in the YTD and longer periods

1
Quartile
quartile-1
QTD
27.72%
1
Quartile
quartile-1
Mar-Jun
73.11%
2
Quartile
quartile-2
Dec-Mar
-12.77%
1
Quartile
quartile-1
YTD
104.14%
4
Quartile
quartile-4
2025
-39.28%
1
Quartile
quartile-1
2024
84.46%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Market Cap stock-summary
Inconsistent Performance

Marksans Pharma Ltd has not been a consistent performer in the YTD and longer periods

1
Quartile
quartile-1
QTD
27.72%
1
Quartile
quartile-1
Mar-Jun
73.11%
2
Quartile
quartile-2
Dec-Mar
-12.77%
1
Quartile
quartile-1
YTD
104.14%
4
Quartile
quartile-4
2025
-39.28%
1
Quartile
quartile-1
2024
84.46%
Click on any of the quartiles for detailed breakdown
stock-summaryRisk Adjusted Returns v/s India SENSEX
stock-summaryReturns Beta
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
Footer loading